Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders

Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders

US Patent 9868711 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial di2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treatin2023
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treatin2023
Process for the production of alpha-tocotrienol and derivatives2022
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treati2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2021
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial di2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2020
Resorcinol compounds for dermatological use2019
Resorcinol compounds for dermatological use2019
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stre2019